Bryn M. Smith

Bryn M. Smith

Auto-generated profile, based on publicly available information

Bryn M. Smith

From the Division of Cardiology (K.T., B.S., N.A.), Department of Medicine, Department of Neurology (D.T., W.T.L.), and Department of Epidemiology (W.T.L.), University of Washington, Seattle

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
KTKarman Tandon
Karman Tandon
DTDavid Tirschwell
David Tirschwell
WLW.T. Longstreth
W.T. Longstreth
BSBryn Smith
Bryn Smith
NANazem Akoum
Nazem Akoum
Objective To examine the hypothesis that atrial fibrosis and associated atrial cardiopathy may be in the causal pathway of cardioembolic stroke independently of atrial fibrillation (AF) by comparing atrial fibrosis burden between patients with embolic stroke of undetermined source (ESUS), patients with AF, and healthy controls. Methods We used late-gadolinium-enhancement MRI to compare atrial fibrosis in 10 patients with ESUS against 10 controls (no stroke, no AF) and 10 patients with AF. Fibrosis was compared between groups, controlling for stroke risk factors. Results Mean age was 51 ± 15 years, and 43% of participants were female. Patients with ESUS had more atrial fibrosis than controls (16.8 ± 5.7% vs 10.6 ± 5.7%, p = 0.019) and similar fibrosis compared to patients with AF (17.8 ± 4.8%, p = 0.65). Odds ratios of ESUS per quartile of fibrosis were 3.22 (95% CI [CI] 1.11–9.32, p = 0.031, unadjusted) and 3.17 (95% CI 1.05–9.52, p = 0.041, CHA2DVASc score adjusted). Patients with >12% fibrosis had a higher percentage of ESUS (77.8% vs 27.3%, p = 0.02), and patients with >20% fibrosis had the highest proportion of ESUS (4 of 5). Conclusions Patients with ESUS exhibit similar atrial fibrosis compared to patients with AF and more fibrosis than healthy controls. Fibrosis is associated with ESUS after controlling for stroke risk factors, supporting the hypothesis that fibrosis is in the causal pathway of cardioembolic stroke independently of AF. Prospective studies are needed to assess the role of anticoagulation in primary and secondary stroke prevention in patients with high atrial fibrosis.

11 November 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
DADaniel M. Arnett
Daniel M. Arnett
JLJames C. Lee
James C. Lee
MHMichael A. Harms
Michael A. Harms
KKKathleen E. Kearney
Kathleen E. Kearney
MRMario Ramos
Mario Ramos
JMJames M. McCabe
James M. McCabe

1 June 2016 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MMMoses Mathur
Moses Mathur
RHRavi S. Hira
Ravi S. Hira
BSBryn M. Smith
Bryn M. Smith
WLWilliam L. Lombardi
William L. Lombardi
JMJames M. McCabe
James M. McCabe

1 June 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
DTDominic M. Tran
Dominic M. Tran
JHJames Harrang
James Harrang
SSShuxian Song
Shuxian Song
JCJeremy Chen
Jeremy Chen
BSBryn M. Smith
Bryn M. Smith
CMCarol H Miao
Carol H Miao

1 December 2018 in Resuscitation
Verified
Journal Article
Closed access
KKKathleen E. Kearney
Kathleen E. Kearney
CMCharles Maynard
Charles Maynard
BSBryn Smith
Bryn Smith
TRThomas D. Rea
Thomas D. Rea
ABAlexis Beatty
Alexis Beatty
JMJames M. McCabe
James M. McCabe

1 November 2017
Verified
Journal Article
Closed access
PHPranoti G Hiremath
Pranoti G Hiremath
KKKathleen Kearney
Kathleen Kearney
BSBryn Smith
Bryn Smith
CDCreighton Don
Creighton Don
DDDanny Dvir
Danny Dvir
JMJames M McCabe
James M McCabe